Clinical Trials Logo

Intra Ocular Pressure clinical trials

View clinical trials related to Intra Ocular Pressure.

Filter by:
  • None
  • Page 1

NCT ID: NCT02508181 Recruiting - Clinical trials for Intra Ocular Pressure

Comparison of Intra Ocular Pressure After Insertion of the LMA Supreme and LMA Proseal in Pediatric Patients

Start date: July 2015
Phase: Phase 4
Study type: Interventional

The investigators enrolled pediatric patients who are undergoing strabismus surgery. The investigators insert either an I-gel or laryngeal mask airway Supreme and measure the intraocular pressures.

NCT ID: NCT02080676 Recruiting - Clinical trials for Intra Ocular Pressure

Effects of Marihuana Use on Optic Nerve Parameters and Ocular Blood Flow

Start date: March 2014
Phase: N/A
Study type: Observational

Purpose of study: to check the effect of medical cannabis given for approved medical indications on ocular parameters including intra ocular pressure, optic nerve fibers thickness and choroidal thickness.

NCT ID: NCT01759914 Terminated - Clinical trials for Topical Corticosteroid-treated Dermatology Patients

Ocular Pressure in Steroid-treated Dermatology Patients

Start date: September 2012
Phase: N/A
Study type: Observational

Ocular hypertension and glaucoma are eye conditions associated with abnormally high fluid pressure in the eye (called intraocular pressure or IOP). If left untreated, the elevated IOP may eventually cause damage to the nerve of the eye and potential impairment of vision. The use of certain drugs has been identified as a risk factor for raised IOP, including various forms of administration of corticosteroids. Corticosteroids can also lead to cataract, which is clouding of the lens in the eye that can affect vision. In this research study, we would like to find out whether the use of corticosteroids in our dermatology clinic leads to raised IOP, in order to identify patients at risk and to allow them to be more closely monitored than others. It is important to identify those patients who have a corticosteroid-induced pressure rise early enough to prevent them from permanent glaucomatous visual loss.